Khan Najat 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed May 19, 2025
Insider Transaction Report
Form 4
Khan Najat
DirectorCEO and President
Transactions
- Tax Payment
Class A Common Stock
2025-05-15$4.25/sh−3,796$16,133→ 708,585 total
Holdings
- 420,226
Stock Option (Right to Buy)
Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 993,944
Stock Option (Right to Buy)
Exercise: $7.34Exp: 2034-08-01→ Class A Common Stock (0 underlying)
Footnotes (3)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F3]This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.